Now I have a solid set of calibration anchors. Let me finalize my assessment.

**Bracketing Analysis:**

The most relevant anchors are:
- **EGraFFBench** (avg 6.00, rejected) — MLFF benchmarking with OOD evaluation. Criticized for questionable implementation, "OOD is hard" not novel, limited technical novelty. One reviewer rated contribution "poor."
- **Understanding & Mitigating Distribution Shifts for MLFFs** (avg 6.25, rejected) — MLFF OOD analysis + mitigation methods. Criticized for modest improvements, practical utility unclear.
- **AU-GOOD framework** (avg 6.67, accepted) — Novel metric for evaluating OOD generalization in biochemical domain. Had genuine framework novelty.
- **JMP / From Molecules to Materials** (avg 5.75, accepted) — Large-scale pre-training, strong results but limited methodological novelty.
- **GDL-DS** (avg 5.67, rejected) — Geometric DL benchmark under distribution shifts. Problematic theory, only 3 datasets, overclaimed.
- **PODGenGraph** (avg 4.50, rejected) — Graph OOD pre-training benchmark. Findings already known, limited novelty.

**My assessment:** GMD-25 is a stronger benchmark contribution than EGraFFBench (6.00) because its task design is more theoretically grounded (compositional generalization theory vs ad-hoc OOD splits) and its findings are more insightful (rankings don't transfer). It's above GDL-DS (5.67) which had theoretical problems, and clearly above PODGenGraph (4.50). It's comparable to but slightly above the AU-GOOD framework (6.67, accepted) — both propose evaluation methodology for OOD generalization, but GMD-25's tasks are more specifically designed and its domain contribution (MLFFs) is distinct.

The energy MAE normalization issue and lack of error bars are real weaknesses but don't invalidate the core contribution (the benchmark design and the qualitative force MAE findings already tell the story). 

**Initial bracket: 6.5 – 7.5. Final score: 7.0.**

---

## Summary
This paper introduces GMD-25, a benchmark for evaluating compositional generalization in Machine Learning Force Fields (MLFFs), comprising four theoretically-motivated tasks (length extrapolation, functional group composition, duplication, and combination) with controlled train/test splits over substituted linear carbon chains. Five models (SchNet, PAINN, DimeNet++, GemNet, EquiFormerV2) are evaluated, revealing that all exhibit large generalization gaps on OOD molecules (often 1–2 orders of magnitude in error increase) and that ID performance rankings do not predict OOD rankings.

## Strengths
- **Principled benchmark design grounded in compositional generalisation theory**: The four tasks are carefully constructed based on specific aspects of compositional generalisation—length generalisation and systematicity (following Hupkes et al., 2020). Each task's train/test split ensures training data covers all atomic sub-components needed for generalisation (Section 3.1, Figure 1). The base/augmented variant design adds diagnostic value by testing whether additional compositional demonstrations help.
- **Consistent evidence of severe generalisation failures across all models**: Across all four tasks and five diverse architectures, OOD errors are consistently 1–2 orders of magnitude higher than ID errors. For Functional Group Duplication, OOD energy MAE errors are higher by two orders of magnitude for all models (Figure 4e; Section 4.3). This provides strong evidence for the central claim.
- **Revealing non-monotonic ID-to-OOD ranking**: EquiFormerV2 achieves the best forces MAE on Length Extrapolation but the worst energy MAE in the OOD region (Figure 2; Section 4.3), while SchNet maintains more stable energy predictions OOD despite weaker ID forces performance. This directly supports the argument that standard benchmarks overstate model reliability.
- **Diverse model evaluation with Bayesian hyperparameter optimization**: Five models spanning invariant GNNs (SchNet), equivariant message passing (PAINN), geometrically-aware architectures (DimeNet++, GemNet), and transformer-based equivariant models (EquiFormerV2) are evaluated with Bayesian hyperparameter optimization to ensure fair comparison (Sections 4.1–4.2).
- **Extensible toolkit and dataset**: Python-based toolkit (ASE, RDKit, FlashMD, GFN2-xTB) with a four-step pipeline, releasing 118 molecules and 296,534 geometries with curated data splits and pre-processing scripts within a companion framework forked from fairchem (Section 3.2).
- **Clean exclusion of foundation models**: Foundation models are explicitly excluded to keep the benchmark focused on architectural inductive biases rather than data coverage confounds (Section 4.1).

## Weaknesses

### Fatal
None

### Major
- **Energy MAE is not normalized per atom**: The energy MAE is defined as (1/M) Σ|Ê_j − E_j| where M is the number of molecules (Section 4.2, equation on line 128), not divided by atom count—unlike force MAE which is properly divided by 3N. For Task 1 (Length Extrapolation), OOD molecules (C7–C13) are systematically larger than training molecules (C2–C6), so a model with constant per-atom error would show a ~2–6× inflation in total energy MAE purely from molecule size. For Task 3 (Duplication), dicarboxylic acid OOD molecules have more atoms than monocarboxylic acid ID molecules at the same chain length. The per-chain-length breakdown in Figure 2 partially mitigates this for Task 1, but the aggregated bar charts in Figure 4 conflate size effects with generalization failure. Reporting per-atom energy MAE alongside the current metric would cleanly separate these effects. The qualitative finding survives via force MAE (properly normalized), but the energy-specific claims are weakened.

- **No variance estimates or multiple runs**: All results are reported from single training runs (Section 4). For a benchmark whose purpose is to rank and compare architectures, this makes it difficult to assess whether model-to-model differences are reproducible or noise. Even 3–5 seeds per model per task would substantially strengthen the credibility of benchmark conclusions.

### Minor
- **Training set size confound not fully disentangled**: The core claim is that models fail due to lack of compositional inductive bias, but for Task 1 base there are only 5 training molecules (~10,000 snapshots). The augmented variants partially address this, but a direct training-set-size ablation showing the gap plateaus would strengthen the argument that the issue is architectural rather than a data scarcity problem.

### Trivial
None

## Nice-to-Haves
- A systematic summary table comparing base vs. augmented generalization gaps across all tasks would strengthen the analysis—the augmented variants are treated narratively rather than analytically.
- Brief quantitative characterization of GFN2-xTB label accuracy for these molecule types, or citation to relevant accuracy studies, would help readers assess whether label noise could affect the generalization gap.
- The connection to algorithmic alignment (Section 2.2) is interesting but underexplored—returning to this in the analysis/discussion would add depth.

## Removed Points
These points are flagged to be removed, treat them with caution.
None — all identified weaknesses were verified against the paper and retained.

## Novel Insights
The paper's most novel finding is the consistent demonstration that ID performance rankings do not predict OOD performance across multiple compositional generalisation tasks and diverse architectures. This has direct practical implications: standard MLFF benchmarks overstate the reliability of models for real molecular discovery, where compositional novelty is the norm. The finding that simpler architectures (SchNet) can outperform more complex ones (EquiFormerV2) on certain OOD metrics, despite weaker ID performance, challenges the assumption that architectural complexity necessarily improves generalisation. The controlled task design based on compositional generalization theory (length generalization, systematicity) is itself a novel contribution to the MLFF benchmarking landscape.

## Suggestions
- Report per-atom energy MAE alongside the current total-energy metric. This is straightforward and would resolve the most consequential methodological concern.
- Run each model with 3–5 random seeds and report mean ± standard deviation for all metrics. This is essential for a benchmark paper intended to guide architectural decisions.
- Add a small training-set-size ablation for at least one task to distinguish architectural limitations from data scarcity.

## Calibration Anchors

| Anchor Paper | Avg Score | Round | Comparison |
|---|---|---|---|
| EGraFFBench | 6.00 (rejected) | R1 | Similar domain (MLFF benchmarking), but weaker task design and questionable implementation quality. GMD-25 has more novel and theoretically grounded benchmark design. |
| Understanding & Mitigating Distribution Shifts for MLFFs | 6.25 (rejected) | R1 | Same domain but combines methods + analysis. GMD-25 is purely a benchmark but with more novel task design. |
| GDL-DS | 5.67 (rejected) | R1 | Geometric DL benchmark under distribution shifts. Had theoretical problems; GMD-25 is cleaner. |
| PODGenGraph | 4.50 (rejected) | R1 | Graph OOD pre-training benchmark. Findings already known; GMD-25's findings are genuinely novel. |
| JMP / From Molecules to Materials | 5.75 (accepted) | R1 | Large-scale pre-training, strong results but limited novelty. Different contribution type. |
| AU-GOOD framework | 6.67 (accepted) | R1 | Novel OOD evaluation metric for biochemical domain. GMD-25 has comparable novelty in MLFF-specific benchmarking. |
| MoleculeCLA | 4.00 (rejected) | R1 | Molecular benchmark via computational analysis. GMD-25 is substantially stronger. |
| Learning Over Molecular Conformer Ensembles | 6.33 (accepted) | R1 | Molecular benchmark. GMD-25 has more targeted and theoretically motivated design. |
| BenchMol | 2.50 (rejected) | R1 | Molecular representation benchmarking platform. Much weaker than GMD-25. |
| Pushing Limits of All-Atom Geom-GNNs | 6.50 (accepted) | R1 | Pre-training + zero-shot transfer for molecular systems. Different contribution type. |
| Redefining Bioactivity Prediction | 7.00 (accepted) | R1 | Benchmark redefinition in drug discovery. Similar spirit of rethinking evaluation methodology. |

**Round 1 bracket: 6.5–7.5.** GMD-25 is clearly above EGraFFBench (6.00, rejected) due to more principled task design and more novel findings, above GDL-DS (5.67) which had theoretical issues, and comparable to the AU-GOOD framework (6.67, accepted) and Redefining Bioactivity Prediction (7.00, accepted). The energy MAE issue and lack of error bars hold it back from the upper end of the bracket. Final score: 7.0.

MY FINAL SCORE: <score>7.0</score>
MY FINAL DECISION: <decision>Accept</decision>